Obesity Medicine

Obesity medication is the field of pharmaceutical devoted to the far-reaching consideration of patients with obese. It is the field of medicine committed to the absolute care of patients with obesityObesity Medicine target on health and disease, relating to the very broad spectrum of research in and strike on humans.Obesity medicine clinicians who are individuals from the Obesity Medicine Association   use an exhaustive, logical, and individualized approach involved nutrition, physical activity, conduct treatment, and prescription to enable patients to get more fit and accomplish better general health.

  • Contrave (naltrexone HCl and bupropion HCl) ; Takeda Pharmaceuticals U.S.A.; For chronic weight management , Approved September 2014
  • Jardiance (empagliflozin) ; Boehringer Ingelheim; For the treatment of type II diabetes, Approved August 2014
  • Saxenda (liraglutide [rDNA origin] injection); Novo Nordisk; For chronic weight management, Approved December 2014
  • Tanzeum (albiglutide); GlaxoSmithKline; For the treatment of type II diabetes mellitus, Approved April 2014
  • Trulicity (dulaglutide); Eli Lilly; To improve glycemic control in type II diabetics, Approved September 2014
  • Nesina (alogliptin); Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
  • Belviq (lorcaserin hydrochloride); Arena Pharmaceuticals; For the chronic management of weight loss, Approved June 2012
  • Bydureon (exenatide extended-release for injectable suspension); Amylin; For the improvement of glycemic control in adults with type II diabetes mellitus, Approved January 2012
  • Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012

Related Conference of Obesity Medicine

March 27-28, 2024

10th International Conference on Gynecology and Obstetrics

Amsterdam, Netherlands
April 11-12, 2024

7th International Conference on Obesity and Chronic Diseases

Amsterdam, Netherlands
June 10-11, 2024

24th Global Summit on Obesity

Dubai, UAE
June 27-28, 2024

20th Euro Obesity and Endocrinology Congress

London, UK
August 29-30, 2024

18th International Conference on Obesity Medicine

Helsinki, Finland

Obesity Medicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in